Psychosocial Care in Liver Transplant Candidates

Psychosocial Care in Liver Transplant Candidates

Structured Summary of Lecture by Dr. Nishi Joshi, Lead Transplant Psychiatrist, Northwell Health

1. Main Clinical Topics Discussed

• The role and scope of transplant psychiatry within the liver transplant multidisciplinary team
• Psychological distress across the transplant continuum (pre-, peri-, and post-transplant phases)
• Psychosocial clearance evaluation: components, ethics, and limitations
• Psychiatric comorbidities and their impact on transplant outcomes
• Alcohol use disorder (AUD) as a specific ethical and clinical challenge in liver transplantation
• Social support as a determinant of post-transplant outcomes
• Body image, self-esteem, and stigma in liver transplant recipients

2. Key Learning Points, Guidelines, and Recommendations

Role of the Transplant Psychiatrist

• Functions as a psychosocial clearance evaluator, not a gatekeeper; the goal is to identify and address modifiable risk factors to optimize candidacy rather than exclude patients outright
• Operates within a modified confidentiality framework: patients must be explicitly informed that disclosures may be shared with the transplant team; transparency is ethically essential
• Serves as both advocate and consultant, balancing patient optimization with team-wide communication
• Collaborates closely with transplant social workers, primary transplant teams, and palliative care

Core Components of Pretransplant Psychosocial Evaluation

• Psychiatric history and current comorbidities: identification of mood/affective disorders (MDD, bipolar disorder), anxiety disorders, and substance use disorders
• Cognitive assessment: establishing baseline cognitive function, particularly relevant given frequent hepatic encephalopathy in liver candidates
• Coping skills assessment: identifying maladaptive coping mechanisms predictive of poor postoperative outcomes
• Treatment adherence capacity: evaluating health literacy, ability to understand and follow complex medical regimens
• Social support evaluation: structured assessment of caregiver availability and reliability, given its demonstrated impact on outcomes

Psychological Timeline of Transplantation

• Pre-transplant phase: acute adjustment reactions; persistent depressive/demoralization states; fear of death; role reversal distress; anticipatory grief
• Peri-transplant/early recovery phase: medication side effects (including mood destabilization from CNIs); body image disruption; unrealistic expectations of recovery; brief "honeymoon" period of hopefulness
• Post-transplant phase: anxiety regarding organ rejection; adjustment to restrictive lifestyle; recurrent hospitalizations; caregiver burden/burnout; late-stage psychological distress persisting beyond one year

Special Considerations for Liver Transplant Candidates

• Higher prevalence of alcohol use disorder (AUD) compared to other organ transplant populations; presents unique ethical complexity
• Body image disturbance is disproportionately prevalent in liver transplant recipients compared to heart, lung, and kidney recipients, with documented impact on rehabilitation participation and quality of life
• Palliative care integration is recommended early — not exclusively for end-of-life purposes, but to facilitate psychological adjustment for patients and families

3. Specific Clinical Data, Statistics, and Study Results Cited

• Literature demonstrates that untreated depression combined with maladaptive coping is associated with increased post-transplant morbidity and mortality in liver transplant patients
• A study (attributed to a transplant psychiatrist, name partially unclear in transcript) specifically examined body image dissatisfaction and post-operative quality of life in liver transplant recipients, finding:

- Liver transplant patients have a higher prevalence of body image-related adjustment disorders than recipients of other solid organs

- Body image disturbance can significantly impair participation in physical rehabilitation and lead to social isolation

• Social support deficits are associated with poor postoperative outcomes, supported by multiple studies referenced in transplant psychiatry literature
• CNI (calcineurin inhibitor)-related neuropsychiatric side effects are well-documented and require ongoing psychiatric monitoring post-transplant

> *Note: Specific statistical figures (e.g., exact prevalence rates) were not fully enumerated in the available transcript segment.*

4. Practical Takeaways for Clinicians

• Screen early and comprehensively: Psychiatric and psychosocial evaluation should occur well before listing; late identification of untre